-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Sabra Health Care REIT, Lowers Price Target to $21

Benzinga·10/19/2026 16:40:02
Listen to the news
Wells Fargo analyst James Feldman maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and lowers the price target from $23 to $21.